Log in to save to my catalogue

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7352972

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma

About this item

Full title

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma

Publisher

Switzerland: MDPI

Journal title

Cancers, 2020-06, Vol.12 (6), p.1449

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Urothelial carcinoma (UC) is a frequent cause of cancer-related deaths worldwide. Metastatic UC has been historically associated with poor prognosis, with a median overall survival of approximately 15 months and a 5-year survival rate of 18%. Although platinum-based chemotherapy remains the mainstay of medical treatment for patients with metastatic...

Alternative Titles

Full title

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7352972

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7352972

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers12061449

How to access this item